Company Description
Achillion Pharmaceuticals is looking for the Achilles heel of infectious disease. The firm is developing biopharmaceutical treatments for...
Key Achillion Financials
| Company Type | Public - NASDAQ (GM): ACHN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $4.0 |
| Employees | -- |
More Achillion Financials (8 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Achillion's competition across multiple industries
Top Achillion Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Achillion Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | Michael D. Kishbauch | Network | E-mail |
| VP and CFO | Mary Kay Fenton | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Achillion News
- Achillion Pharmaceuticals, Inc. (ACHN) Corporate Event Announcement Notice [Wall Street Horizon] (19 Jul 2008 20:38:00 EDT)
- Achillion Pharmaceuticals, Inc. (ACHN) Corporate Event Announcement Notice [Wall Street Horizon] (18 Jul 2008 20:38:00 EDT)
- COMBINATION THERAPY FOR TREATING HEPATITIS C INFECTIONS [PCT Biblio Info] (01 Jul 2008 13:16:00 EDT)